Pharmaceutical

NImmune and BioTherapeutics partner on precision medicine development

NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and immunology.

Sep 8, 2024 - 04:00
NImmune and BioTherapeutics partner on precision medicine development
NImmune Biopharma and BioTherapeutics have partnered to develop new precision medicines in the field of inflammation and immunology.
Read the original article

Tags:

Previous Article

FDA grants ODD to Abdera’s neuroendocrine carcinoma treatment

Next Article

Evotec partners X-Chem for tech-enabled drug discovery

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novo Nordisk and Broad Institute to explore drug targets for diabetes, CMDs 

Novo Nordisk and Broad Institute to explore drug target...

Sep 7, 2023

Targovax announces plans to rebrand as Circio

Targovax announces plans to rebrand as Circio

Apr 20, 2023

STAT+: Springworks wins FDA approval for drug to treat desmoid tumors

STAT+: Springworks wins FDA approval for drug to treat ...

Nov 27, 2023